Wyoming, MI 的 潰瘍性結腸炎 臨床試驗
7 項針對 潰瘍性結腸炎 的研究正在 Wyoming（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
招募中2 期
- West Michigan Clinical Research Center /ID# 280480, Wyoming
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
招募中4 期
- Gastroenterology Associates of Western Michigan, P.L.C., Wyoming
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
招募中2 期
- Gastroenterology Associates of Western Michigan, P.L.C., Wyoming
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
招募中2 期
- Gastroenterology Associates of Western Michigan, PLC d.b.a. West Michigan Clinical Research Center, Wyoming
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
招募中2 期
- Gastroenterology Associates of Western Michigan, PLC d.b.a. West Michigan Clinical Research Center, Wyoming
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
招募中3 期
- Gastroenterology Associates of Western Michigan - Site Number: 8400060, Wyoming
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
招募中3 期
- Gastroenterology Associates of Western Michigan - Site Number: 8400060, Wyoming
其他城市的 潰瘍性結腸炎 試驗
- New York City, NY23 項研究
- Orlando, FL22 項研究
- Miami, FL21 項研究
- Houston, TX17 項研究
- San Antonio, TX16 項研究
- Chicago, IL15 項研究
- Tacoma, WA15 項研究
- San Diego, CA15 項研究
- Tyler, TX14 項研究
- Colorado Springs, CO14 項研究
- Los Angeles, CA13 項研究
- St. Louis, MO13 項研究
Wyoming 的其他研究
- 非小細胞肺癌6 項研究
- 黑色素瘤6 項研究
- 乳癌6 項研究
- 大腸直腸癌6 項研究
- 克隆氏症6 項研究
- 肺癌5 項研究
- 結腸癌5 項研究
- 中風5 項研究
- 膀胱癌4 項研究
- 消化系統疾病4 項研究
- 子宮內膜癌3 項研究
- 異位性皮膚炎（濕疹）3 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。